A B S T R A C T The role of the renin-angiotensin system in the regulation of the systemic and coronary circulations during sodium depletion was studied in conscious normotensive dogs by i.v. administration of teprotide (0.5 mg/kg), an angiotensin-converting enzyme inhibitor, and saralasin (0.05-5 ,ug/kg per min), an angiotensin-receptor antagonist. Sodium depletion was produced by administering a low sodium diet and furosemide for 5 days. Administration of both teprotide and saralasin lowered systemic arterial blood pressure and total peripheral vascular resistance. Simultaneously, cardiac output increased, but left ventricular end-diastolic pressure, dP/dt, and dP/dt/P did not change significantly. Furthermore, both agents reduced diastolic coronary vascular resistance and increased coronary blood flow, but did not affect myocardial oxygen consumption, left ventricular work, or myocardial efficiency. These systemic and coronary vasodilator effects of teprotide and saralasin, however, were not observed in normal dogs on a regular sodium diet; in this group, the only effect noted was a slight increase in arterial pressure during saralasin infusion. Arterial plasma concentration of norepinephrine did not differ between normal and sodiumdepleted dogs, nor did it change significantly after teprotide administration. These results suggest that, vessels, but has no significant effects on myocardial contractility or energetics. It also appears likely that the increase in cardiac output observed in sodiumdepleted dogs after angiotensin inhibition was caused, at least in part, by the decrease in systemic arterial pressure.
INTRODUCTION
Sodium depletion increases plasma renin activity (PRA)l and blood angiotensin II concentration (1) (2) (3) , indicating an activation of the renin-angiotensin system. This increase in 'angiotensin II concentration probably plays an important role in the maintenance of normal arterial blood pressure during salt depletion, because the arterial blood pressure decreases under these conditions after administration of saralasin (1-sarcosine-8-alanine-angiotensin II; P113) (2-7), teprotide (SQ 20,881) (7) (8) (9) (10) , and SQ 14, 225 (11) . Saralasin is a competitive receptor antagonist of angiotensin II (4, 12, 13) , whereas the latter two agents inhibit angiotensin-converting enzyme, which converts angiotensin I to the biologically active angiotensin II (8, (13) (14) (15) (16) . Because angiotensin II is one of the most potent vasoconstrictors known (17, 18) , a decrease in arterial blood pressure after angiotensin inhibition presumably is due to elimination of the angiotensin-induced vasoconstriction. However, angiotensin II also exerts a positive inotropic action on the heart (19, 20) , the abolition of which may lower the arterial pressure. Previous investigators (9, 10) have shown that cardiac output de- creased in anesthetized salt-deprived rats after teprotide administration. The physiologic role of the renin-angiotensin system on myocardial contractility during salt depletion, however, has not been investigated.
The present study was undertaken to determine the effects of saralasin and teprotide on cardiac output, myocardial mechanical function, and total peripheral vascular resistance in salt-depleted conscious dogs. Also studied was the possible role of the reninangiotensin system in the regulation of coronary circulation during salt depletion. Angiotensin II may affect the coronary blood flow and vascular resistance either directly by its coronary vasoconstrictor action or indirectly by systemic vasoconstriction, which increases cardiac work and myocardial oxygen consumption (20, 21) . Furthermore, because saralasin may exert a dose-dependent agonistic action on angiotensin receptors (12, 22, 23) , three doses of saralasin were administered. Results of this study indicate that angiotensin II exerts an active vasoconstrictor action on the systemic and coronary vessels during salt depletion, but has no significant effect on myocardial contractility or energetics.
METHODS
Adult male beagles between 6 (25) . Coronary blood flow was measured by a 4-aminoantipyrine indicator method (26, 27) . Diastolic Teprotide (0.5 mg/kg) was injected i.v., and systemic hemodynamic measurements were repeated at 5-min intervals for 30 min thereafter. Coronary blood flow was determined 20 min after teprotide administration. Pharmacologic inhibition of angiotensin-converting enzyme was assessed by measuring aortic pressor responses to angiotensin I (0.5 ,ug, Schwarz/Mann Div., Becton, Dickinson & Co., Bioresearch, Inc., Orangeburg, N. Y.) given i.v. before, and 30 min after, teprotide administration.
Saralasin was administered by i.v. infusion at rates of 0.05, 0.5, and 5 ,ug/kg per min, each for 20 min. The agent was diluted serially with normal saline for each dose and infused at a rate of 0.229 ml/min with a Harvard pump (Harvard Apparatus Co., Inc., Millis, Mass.). At the time of each infusion, systemic hemodynamic measurements were obtained every 5 min, and coronary blood flow every 20 min. The pressor response to angiotensin II (0.5 .g, i.v.; Hypertensin, CIBA Pharmaceutical Co., Summit, N. J.) was measured at the control period and at 20 min ofeach infusion to determine the degree ofangiotensin II receptor blockade.
Experimental results were subjected to analysis of variance for repeated measures (31) ; the statistical significance of differences between the control and experimental values was determined by Dunnett's test (32) , changes being considered statistically significant if P values are <0.05. Student's t test was used to detennine the statistical significance of a difference between two means.
RESULTS
Effects of sodium depletion. A significant cumulative negative sodium balance (-84±11 meq; mean -SE; n = 15) occurred in dogs that received a low sodium diet and furosemide. PRA was significantly higher in these sodium-depleted dogs (19.4±4.4 ng/ml per h) than in thQ normal controls (6.2+1.6 ng/ml per h, n = 14; P < 0.05). Figs. 1 and 2 show that pressor responses to angiotensin I and II were attenuated by sodium depletion. Also, compared to those in normal dogs, cardiac output and left ventricular end-diastolic pressure were lower, and total peripheral vascular resistance higher, in sodium-depleted dogs (Tables I and II) . Other hemodynamic parameters did not differ between the two groups. Arterial blood pH and gases were within the physiological range in both normal and sodium-depleted dogs and did not change significantly after administration of either teprotide or saralasin.
Effects of teprotide administration. Teprotide administration significantly reduced the arterial pressor response to angiotensin I (Fig. 1 ). In the sodiumdepleted dogs, administration of teprotide decreased systemic arterial pressure and total peripheral vascular resistance (Fig. 3 , Table I ). Cardiac output and stroke volume increased, but left ventricular end-diastolic pressure, dP/dt, and dP/dt/P did not change significantly. A (Fig. 3) .
Teprotide also caused an increase in coronary blood flow in sodium-depleted dogs (Table III) . Coronary sinus oxygen content increased (44±7-78±7 ml/liter) and myocardial oxygen extraction decreased. Diastolic coronary vascular resistance fell, but neither left ventricular work nor myocardial efficiency changed significantly.
These systemic and coronary vascular effects of teprotide, however, did not occur in the normal dogs (Tables I and III Effects of saralasin infusions. Fig. 2 shows that the pressor response to angiotensin II progressively decreased after successive infusions of saralasin. As with teprotide administration, saralasin infusion decreased systemic arterial blood pressure and total peripheral vascular resistance in the sodium-depleted dogs (Fig. 4 , Table II ). Cardiac output increased slightly, but heart rate, stroke volume, left ventricular end-diastolic pressure, dP/dt, and dP/dt/P did not change significantly.
Coronary blood flow increased slightly in sodiumdepleted dogs during the lowest-dose infusion of saralasin but returned toward the preinfusion value at higher doses (Table IV) . Diastolic coronary vascular resistance fell during all doses of saralasin infusion. Myocardial oxygen extraction, myocardial oxygen consumption, left ventricular work, and myocardial efficiency did not change.
In normal dogs, saralasin infusion increased arterial pressure slightly during the middle-dose infusion of saralasin, but there were no changes in other hemodynamic parameters measured (Fig. 4 , Tables II and IV).
DISCUSSION
Sodium depletion was produced in the present experiments by a low sodium intake and by administration of furosemide (1, 17, 33) . Hypovolemia probably was responsible for the reduced cardiac output and left ventricular end-diastolic pressure in these sodium-depleted dogs. The increased secretion of renin was evidenced in the present study by the increase in PRA and attenuated pressor responses to angiotensin injection. It has been well documented that the angiotensin pressor response correlates directly with sodium balance but inversely with PRA (34) (35) (36) . This decrease in pressor activity of exogenous angiotensin during salt depletion may be the result Values are means ± SE at a preinfusion control period (C), and at 20 min during each ofthe successive saralasin infusions at rates of0.05 (1),0.5 (2), and 5.0 (3) ,ug/kg per min. The numbers ofexperiments and body weights ofthe dogs are the same as in Table II . * Values that are different from the control at P < 0.05, as determined by Dunnett's test (32) . attenuated responses to injected angiotensin I and II (Figs. 1 and 2) . Angiotensin II may produce cardiovascular changes indirectly by its actions on the central and peripheral sympathetic pathways. Centrally, angiotensin stimulates the area postrema, which modulates medullary vasomotor activity. In the peripheral sympathetic system, angiotensin has been shown to stimulate sympathetic ganglia and the adrenal medulla, to potentiate neurotransmitter biosynthesis and release, and to inhibit reuptake of norepinephrine at the nerve endings (37) . Our arterial plasma norepinephrine measurements, however, did not indicate an increase in sympathetic activity during salt depletion. It appears likely that during high renin states angiotensin II acts to maintain normal arterial blood pressure by its direct vasoconstrictor action (20, 21) .
Teprotide produced no systemic hemodynamic effects in normal dogs, suggesting that the reninangiotensin system plays no important role in maintaining arterial blood pressure in dogs on a regular sodium diet. In contrast, arterial blood pressure increased transiently in normal dogs during saralasin infusion, probably because of the partial agonist effect of saralasin. These results also indicate that neither agent has primary vasodepressor effects in normal dogs, and that the vasodilation produced by both agents in sodium-depleted dogs probably is related to the high angiotensin II level. Nevertheless, it may still be possible that a primary drug-induced vasodilation may occur during sodium depletion.
Cardiac output increased in salt-depleted dogs after teprotide administration and during saralasin infusion. This increase in cardiac output was associated with a decrease in mean aortic pressure, whereas neither left ventricular end-diastolic pressure nor myocardial contractility changed significantly. Vasodilators, such as nitroprusside, have been shown to increase cardiac output during heart failure (38) . Nitroprusside, however, has no significant action on cardiac output in normal subjects (39) , probably because it also dilates capacitance vessels and reduces the filling pressure of the heart, thus offsetting the effects of afterload reduction on cardiac output. Cardiac output, nevertheless, increases significantly in normal animals during nitroprusside infusion when the filling pressure of the heart is maintained (40) . In our experiments in sodiumdepleted dogs, inhibition of angiotensin, which has its predominant effect on resistance vessels (18) , de- creased aortic blood pressure but had no effect on the left ventricular end-diastolic pressure. The decrease in aortic pressure may have been responsible for the increased cardiac output, as occurs when filling pressures are maintained during nitroprusside infusion, or after other maneuvers that reduce ventricular afterload without affecting the capacitance vessels (41) (42) (43) .
Previous investigators (9, 10) reported that cardiac output decreased in salt-depleted anesthetized rats after teprotide administration. However, in their experiments neither cardiac output nor systemic vascular resistance was altered by salt depletion, in apparent contradiction to our present study as well as the studies of others (2) in conscious dogs. Myocardial contractility was not measured in the rat experiments. The differences in species, degree of sodium depletion, and experimental methods might account for the variation in experimental results.
Coronary blood flow increased in salt-depleted dogs after angiotensin inhibition. The association of increased coronary blood flow with an increase in coronary sinus oxygen content and a decrease in myocardial oxygen extraction (Table III) suggests that an active coronary vasodilation occurred 20 min after teprotide administration. These effects of teprotide, however, are short-lived, because coronary blood flow returns toward control values after an additional 20 min, although systemic and coronary vascular resistances are still decreased (unpublished observations). Likewise, coronary blood flow only increased significantly within the first 20 min of saralasin infusion; however, in this instance, the magnitude of the flow increase was small, and was not associated with significant narrowing of the coronary arteriovenous oxygen difference.
Coronary blood flow is determined largely by myocardial metabolic demand, which may offset the coronary vascular effects of neural or humoral mechanisms (44, 45) . In the control state in these experiments, before angiotensin inhibition, coronary blood flow and diastolic vascular resistance in normal and sodium-depleted dogs did not differ. Thus, there was no evidence that sustained stimulation of the reninangiotensin system as a result of salt depletion and furosemide administration over a 5-day period influenced the normal relationship between coronary flow and myocardial metabolic demand. However, when the renin-angiotensin system was inhibited acutely by saralasin or teprotide in the salt-depleted animals, there was a prompt decrease in coronary vascular resistance and an increase in coronary blood flow. The findings suggest that the known vasoconstrictor effects of renin-angiotensin system activation upon the systemic vasculature are shared by the coronary vascular bed. This is consistent with the view that the coronary vessels are at least as sensitive to the constrictor effects of angiotensin as are vessels in skin and skeletal muscle (46) . The increase in coronary blood flow produced by saralasin and teprotide, however, disappeared after 40 A decrease in aortic pressure may activate the baroreceptor reflex, which increases coronary blood flow by stimulating the myocardium to increase contractility and heart rate. Stimulation of cardiac sympathetic nerves also produces a direct constrictor effect on coronary vessels, but the indirect myocardial effects usually predominate (44) . Massive sympathetic discharges probably did not occur as aortic pressure decreased during angiotensin inhibition in our experiments. Plasma norepinephrine concentration did not increase after teprotide administration, nor did myocardial contractility change significantly after administration of teprotide or saralasin. Heart rate increased only slightly 25-30 min after teprotide administration. In addition, the responsiveness of the efferent sympathetic nervous system of the baroreceptor reflex is decreased during salt depletion (47) . It seems unlikely that sympathetic activation could have played a major role in causing the systemic and coronary hemodynamic changes observed in our study.
Teprotide is known to inhibit kininase and to augment the effects of bradykinin (14, 48, 49) . Bradykinin exerts considerable vasodilator activity on systemic and coronary vascular beds. It decreases arterial pressure, and increases cardiac output and coronary blood flow in dogs (18, 50) . Results of the present study, however, do not allow us to define the role of this bradykinin-potentiating effect of teprotide on systemic and coronary hemodynamics in normal and sodium-depleted dogs. The fact that both teprotide and saralasin produced qualitatively similar changes suggests that these effects are primarily the result of blockade of the renin-angiotensin system. The quantitative differences in the effects of teprotide and saralasin on systemic and coronary vascular resistances may be due to the slightly higher preinfusion control values in the teprotide groups, the partial agonist effects of saralasin, or the bradykinin-potentiating action of teprotide.
In summary, the present experiments show that activation of the renin-angiotensin system during sodium depletion contributes to circulatory homeostasis through vasoconstriction, but has no effect upon myocardial contractility or energetics. Under these conditions, blockade of the renin-angiotensin system lowers peripheral vascular resistance 
